Hanmi Pharmaceutical Group's year-long family feud over management control is poised to end, as a pivotal share transfer shifts power within the founding family. From left: Shin Dong-kuk, chairman ...

LOS ANGELES, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Hanmi Financial Corporation (NASDAQ: HAFC, or “Hanmi”), the parent company of Hanmi Bank (the “Bank”), today announced that its Board of ...

LOS ANGELES, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Hanmi Financial Corporation (NASDAQ: HAFC, or “Hanmi”), the parent company of Hanmi Bank (the “Bank”), today reported financial results for ...

Eli Lilly has opted to end a phase 2 rheumatoid arthritis (RA) trial of a drug it is developing with Korea’s Hanmi Pharmaceuticals, according to press reports. The Korea Biomedical Review cited ...

(RTTNews) - Hanmi Financial Corporation (HAFC) reported a profit for fourth quarter that decreased from last year but beat the Street estimates. The company's earnings came in at $17.70 million ...

Hanmi Pharmaceutical CEO Park Jae-hyun at the extraordinary shareholder meeting held in Songpa District, southern Seoul, on Thursday. [YONHAP] Efforts to seize the management rights of Hanmi ...

Roche’s Genentech unit is to partner with South Korea’s Hanmi Pharmaceutical, to develop and market a phase 1 cancer drug, in a deal potentially worth over $900 million. Under the agreement ...

LOS ANGELES, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Hanmi Financial Corporation (NASDAQ: HAFC, or “Hanmi”), the parent company of Hanmi Bank (the “Bank”), today announced its participation in ...

LOS ANGELES, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Hanmi Financial Corporation (Nasdaq: HAFC) (“Hanmi”), the holding company for Hanmi Bank, today announced that it will report fourth quarter 2024 ...

LOS ANGELES, Jan. 14, 2025 (GLOBE NEWSWIRE) -- Hanmi Financial Corporation (Nasdaq: HAFC) (“Hanmi”), the holding company for Hanmi Bank, today announced that it will report ...